We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
A Pathway to Publishing an Oncology Nursing Book.
Seminars in Oncology Nursing 2018 November
OBJECTIVES: To describe the process of book publishing, including authoring and revising book chapters, and provide resources on book publishing opportunities for oncology nurses.
DATA SOURCES: Journal articles, book publishers' information for authors, online publishing resources, discussions with textbook editors, personal experience.
CONCLUSION: Few published resources exist to guide nurses as they author and/or revise books and book chapters. In addition, book publishing presents unique considerations, such as authorship of subsequent editions, and new opportunities, such as self-publishing and electronic textbook formats.
IMPLICATIONS FOR NURSING PRACTICE: Textbooks are enduring repositories of comprehensive information used by both students and clinicians. Oncology nurses have expert research and clinical expertise that can contribute to this body of published nursing knowledge and ultimately improve the care of people with cancer.
DATA SOURCES: Journal articles, book publishers' information for authors, online publishing resources, discussions with textbook editors, personal experience.
CONCLUSION: Few published resources exist to guide nurses as they author and/or revise books and book chapters. In addition, book publishing presents unique considerations, such as authorship of subsequent editions, and new opportunities, such as self-publishing and electronic textbook formats.
IMPLICATIONS FOR NURSING PRACTICE: Textbooks are enduring repositories of comprehensive information used by both students and clinicians. Oncology nurses have expert research and clinical expertise that can contribute to this body of published nursing knowledge and ultimately improve the care of people with cancer.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app